It's interesting to look at the full process of cancer, how it is created in the body and how the body removes cancer masses on its own for spontaneous remission.

Cancers occur when stresses trigger the anaerobic metabolic cycle in a cell that appears as uncontrolled growth. Cancer is a cellular survival mechanism and a reflection of combined stresses affected the environment of a cell. The stresses usually include energetic levels that come from the soul and psyche, such as emotional traumas and psychological shocks or conflicts. In the German New Medicine model pioneered by Dr. Hamer (now also incorporated into healing systems such as Meta-Medicine/Lifestyle Prescriptions and Biodecoding) the mind-brain-organ relays of cancer and other diseases are mapped along with a predictable cycle of phases of symptoms related to the stress/trauma and recovery when the stress has passed or resolved. Thus, with cancer the body works symbiotically with microbes such as viruses to help remove cancer cells once the need for those cells has passed. The viruses break down the cancer cells and the immune system brings a fever (to help the break down of cancer cells and keep the viral activity from affecting normal healthy cells) and immune cells come to the scene to clear the leftover debris.

There is an extraordinary inner intelligence at work.

Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer.

https://www.ncbi.nlm.nih.gov/pubmed/15596850?fbclid=IwAR21eQUS4te2wrOvrZbhyDQpU_RarCyoEenfU3gOKp-puK02--I640XoF9c

- Jedi

www.phinsights.com/links.html

: by Tyler Durden
: Sat, 01/25/2020

: Every once in a while, medical researchers simply have a

: stroke of good luck. In this case, that "stroke of
: good luck" could have a profound effect on the medial
: community.

: Researchers at Cardiff University that were in the midst of
: analyzing blood from a bank accidentally stumbled into an
: "entirely new type of T-cell", according to The
: Daily Wire. The new cell carries a "never before
: seen" type of receptor that acts like a grappling
: hook, latching on to most human cancers.

: Prior therapies, called CAR-T and TCR-T, which use immune
: cells to attach to HLA molecules on cancer cells' surface,
: are incapable of fighting solid tumors, the article notes.
: HLA molecules vary in people, but the new therapy instead
: attaches to a molecule called MR1, which does not vary in
: humans. This gives the therapy a chance of fighting most
: cancers.

: It also means people could share the treatment, which could
: allow banks of cells to be stored and offered quickly, as
: needed.

: SNIP